Eloctate with Fc Fusion Protein recombinant e Eventi cardiovascolari
Risultato del controllo d'interazione tra il farmaco Eloctate with Fc Fusion Protein recombinant e la malattia Eventi cardiovascolari su sicurezza in caso d'uso simultaneo.
Durante il controllo d'interazione, secondo le fonti autorevoli Drugs.com, Rxlist.com, Webmd.com, Medscape.com non sono trovate le controindicazioni o gli effetti collaterali. È permesso prendere il farmaco in presenza di questa malattia concomitante dopo il controllo addizionale e l’approvazione del proprio medico.
Nome generico: antihemophilic factor
Marchio commerciale: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Sinonimo: Eloctate with Fc Fusion Protein (recombinant), Eloctate
Eloctate with Fc Fusion Protein recombinant - zdarzenia sercowo-naczyniowe 
Eloctate with Fc Fusion Protein recombinant - eventos cardiovasculares 
Eloctate with Fc Fusion Protein recombinant - Peristiwa kardiovaskular 
Eloctate with Fc Fusion Protein recombinant - Acara kardiovaskular 
Eloctate with Fc Fusion Protein recombinant - événements cardiovasculaires 
Eloctate with Fc Fusion Protein recombinant - kardiovaskuläre Ereignisse 
Eloctate with Fc Fusion Protein recombinant - Eventos cardiovasculares 
Eloctate with Fc Fusion Protein recombinant - сердечно-сосудистые события 
Eloctate with Fc Fusion Protein recombinant - cardiovascular Events 
Eloctate with Fc Fusion Protein recombinant - kardiyovasküler olaylar 
Eloctate with Fc Fusion Protein recombinant - أحداث القلب والأوعية الدموية 
Eloctate with Fc Fusion Protein recombinant - 心血管事件